Prioritize patient safety and healthcare advancement!

A crucial NCVHS meeting rejected UDI inclusion in claims. The FDA is urged to review stakeholder input for patient safety. Medical device companies, like Medtronic, opposed UDI inclusion, why? Medtronic has over 450 open Recalls and is unable to trace these at-risk devices. The UDI is vital for risk identification, patient outcomes, patient safety, and cost savings.

The FDA must reinforce UDI regulations. Stay vigilant, and engage with the FDA and healthcare partners.

#disappointed #fdadevicehelp #cdrh #medicaldevicesafety #patientsafety #udi #knowyourudi #medicaldeviceregulations

Previous
Previous

CDRH Advisory Committee Meeting: to discuss and make recommendations on medical device supply chain resiliency and shortage issues, including the 506J Device List

Next
Next

Safeguard patients and achieve compliance effortlessly with our groundbreaking solution.